Weber Brittany, Portnoy Joel E, Castellanos Andres, Hawkshaw Mary J, Lurie Deborah, Katz Philip O, Sataloff Robert T
Department of Otolaryngology - Head and Neck Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania; Department of Otolaryngology, Eastern Virginia Medical School, Norfolk, Virginia.
Department of Otolaryngology - Head and Neck Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania; Voice and Swallowing Center, ENT and Allergy Associates, Lake Success, New York.
J Voice. 2014 Jul;28(4):492-500. doi: 10.1016/j.jvoice.2013.12.009. Epub 2014 Mar 12.
Laryngopharyngeal reflux (LPR) is a pervasive disorder that may cause hoarseness, throat clearing, and other symptoms. These symptoms are particularly problematic in professional voice users. Proton pump inhibitors (PPIs) are the mainstay of current medical management for LPR but may be insufficient in managing some patients' symptoms. Laparoscopic Nissen fundoplication (LNF) is well established for treatment of gastroesophageal reflux disease with a high success rate, but its role in the treatment of LPR remains uncertain. This study was designed to investigate the effectiveness of anti-reflux surgery in managing disease refractory to medical reflux therapy (twice of more per day PPIs).
Retrospective medical record review.
This study examined 25 professional voice users, age ranging from 14 to 75 years, diagnosed with refractory LPR treated twice daily or more with PPIs. Reflux finding scores (RFS) were graded by blinded raters and compared for initial, preoperative, postoperative, and final visits. Twenty-four-hour pH-impedance study scores were obtained pre- and postoperatively.
Sixty percent of patients were on no-reflux medications postoperatively and an additional 24% were on less medication. RFS was not significantly different between pre- and postoperative evaluations with good inter- and intrarater reliability; postoperative examinations occurred on less or no pharmaceutical reflux treatment. Twenty-four-hour pH-impedance testing revealed significant reductions in reflux and a nearly significant reduction in total acid. Ninety percent of positive symptom indices preoperatively were negative postoperatively. Seventy-six percent of patients on BID dosing of PPIs and 86% of those receiving super-high-dose PPI administration who underwent LNF were satisfied with the results for their LPR disease.
LNF should be considered as a treatment option for professional voice users with LPR with symptoms refractory to standard or super-high-dose medical management. LNF may decrease or eliminate the need for postoperative PPI usage. The RFS may not be sensitive enough to monitor changes in LPR severity. Patients, especially those on super-high-dose medication administration, are satisfied with the improvement in LPR symptoms after anti-reflux surgery.
喉咽反流(LPR)是一种普遍存在的疾病,可导致声音嘶哑、清嗓及其他症状。这些症状在职业用嗓者中尤其成问题。质子泵抑制剂(PPI)是目前LPR药物治疗的主要手段,但在控制某些患者的症状方面可能并不充分。腹腔镜下尼氏胃底折叠术(LNF)在治疗胃食管反流病方面已确立了较高的成功率,但其在LPR治疗中的作用仍不确定。本研究旨在调查抗反流手术对药物反流治疗(每天使用PPI两次或更多)无效的疾病的疗效。
回顾性病历审查。
本研究检查了25名年龄在14至75岁之间、被诊断为难治性LPR且每天使用PPI两次或更多的职业用嗓者。反流发现评分(RFS)由不知情的评估者分级,并在初次、术前、术后和最后一次就诊时进行比较。术前和术后均获得24小时pH阻抗研究评分。
60%的患者术后不再使用抗反流药物,另外24%的患者用药量减少。术前和术后评估的RFS无显著差异,评估者间和评估者内的可靠性良好;术后检查时药物反流治疗减少或未进行。24小时pH阻抗测试显示反流显著减少,总酸几乎显著减少。术前90%的阳性症状指标术后变为阴性。接受LNF的每日两次服用PPI的患者中有76%以及接受超高剂量PPI治疗的患者中有86%对其LPR疾病的治疗结果感到满意。
对于症状对标准或超高剂量药物治疗无效的LPR职业用嗓者,应考虑将LNF作为一种治疗选择。LNF可能会减少或消除术后使用PPI的需求。RFS可能不够敏感,无法监测LPR严重程度的变化。患者,尤其是那些接受超高剂量药物治疗的患者,对抗反流手术后LPR症状的改善感到满意。